Literature DB >> 35484426

Therapeutic Effects of High-Intensity Interval Training Exercise Alone and Its Combination with Ecdysterone Against Amyloid Beta-Induced Rat Model of Alzheimer's Disease: A Behavioral, Biochemical, and Histological Study.

Hesam Parsa1, Mahdi Ramezani2, Parsa Gholipour3,4, Alireza Komaki4.   

Abstract

Hippocampal oxidative stress has a vital role in the pathophysiology of Alzheimer's disease (AD)-associated behavioral deficits. Ecdysterone (Ecdy), a natural product and primary steroid hormone, exhibits anti-oxidative and neuroprotective effects. High-intensity interval training (HIIT) has emerged as an effective method for improving physiological brain functions. The present study was designed to investigate the comparative effects of separate and combined HIIT and Ecdy treatment on behavioral functions, hippocampal oxidative status, histological changes in an amyloid-beta (Aβ)-induced rat model of AD. Adult male rats were treated simultaneously with HIIT exercise and Ecdy (10 mg/kg/day; P.O.), starting ten days after Aβ-injection, and they continued for eight consecutive weeks. At the end of the treatment course, the behavioral functions of the rats were assessed by commonly-used behavioral paradigms. Subsequently, brain samples were collected for histological analysis and hippocampus samples were collected for biochemical analysis. Results illustrated that Aβ injection impaired learning and memory performances in both novel object recognition and Barnes maze tests, reduced exploratory/locomotor activities in open field test, enhanced anxiety-like behavior in elevated plus-maze (P < 0.05). These behavioral deficits accompanied hippocampal oxidative stress (decreased total antioxidant capacity content and glutathione peroxidase enzyme activity, increased total oxidant status and malondialdehyde level) and neuronal loss in the cerebral cortex and hippocampus in H&E staining (P < 0.05). HIIT and Ecdy improved anxiety-like behavior, attenuated total oxidant status and malondialdehyde, and prevented the neuronal loss (P < 0.05). However, their combination resulted in a more complete and powerful improvement in all the above-mentioned Aβ-related deficits (P < 0.05). Overall, these data provide evidence that a combination of HIIT and Ecdy treatment improves Aβ-induced behavioral deficits, possibly through ameliorating hippocampal oxidative status and preventing neuronal loss.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease (AD); Ecdysterone; High Intensity Interval Training (HIIT); Learning; Oxidative stress; β-Amyloid (Aβ)

Mesh:

Substances:

Year:  2022        PMID: 35484426     DOI: 10.1007/s11064-022-03603-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  74 in total

Review 1.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

2.  Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration.

Authors:  A Nitta; T Fukuta; T Hasegawa; T Nabeshima
Journal:  Jpn J Pharmacol       Date:  1997-01

3.  The adverse impact of type 2 diabetes on brain volume in heart failure.

Authors:  Michael L Alosco; Adam M Brickman; Mary Beth Spitznagel; Erica Y Griffith; Atul Narkhede; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Clin Exp Neuropsychol       Date:  2013-02-18       Impact factor: 2.475

Review 4.  Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.

Authors:  Tianfang Jiang; Qian Sun; Shengdi Chen
Journal:  Prog Neurobiol       Date:  2016-10-18       Impact factor: 11.685

5.  Beta-asarone attenuates neuronal apoptosis induced by Beta amyloid in rat hippocampus.

Authors:  Jicheng Liu; Chengchong Li; Guihua Xing; Li Zhou; Miaoxian Dong; Yutao Geng; Xueyan Li; Jiaming Li; Gang Wang; Dejia Zou; Yingcai Niu
Journal:  Yakugaku Zasshi       Date:  2010-05       Impact factor: 0.302

Review 6.  Modifiable factors that alter the size of the hippocampus with ageing.

Authors:  Majid Fotuhi; David Do; Clifford Jack
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

7.  Steroid metabolism in cnidarians: insights from Nematostella vectensis.

Authors:  Ann M Tarrant; Adam M Reitzel; Charles H Blomquist; Ferdinand Haller; Janina Tokarz; Jerzy Adamski
Journal:  Mol Cell Endocrinol       Date:  2008-10-15       Impact factor: 4.102

Review 8.  Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects.

Authors:  Haroon Khan; Surriya Amin; Mohammad Amjad Kamal; Seema Patel
Journal:  Biomed Pharmacother       Date:  2018-03-22       Impact factor: 6.529

9.  Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.

Authors:  Paula L McClean; Christian Hölscher
Journal:  Neuropharmacology       Date:  2013-08-21       Impact factor: 5.250

10.  The effect of green tea consumption on oxidative stress markers and cognitive function in patients with Alzheimer's disease: A prospective intervention study.

Authors:  Horrolein Arab; Soleiman Mahjoub; Karimollah Hajian-Tilaki; Mehdi Moghadasi
Journal:  Caspian J Intern Med       Date:  2016
View more
  1 in total

Review 1.  Research trends and hotspots of exercise for Alzheimer's disease: A bibliometric analysis.

Authors:  Binglin Chen; Yujie Fu; Ge Song; Weiquan Zhong; Jiabao Guo
Journal:  Front Aging Neurosci       Date:  2022-09-07       Impact factor: 5.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.